Joe Landolina on promoting a breakthrough in hemostasis

Joe Landolina is the co-founder and CEO of Cresilon, a groundbreaking biotechnology company specializing in hemostatic solutions for both human and veterinary medicine. In other words, bloodwork. With a background in biomolecular and chemical engineering, Landolina is the inventor of Vetigel, a revolutionary plant-based gel that rapidly stops bleeding. His innovation has transformed emergency care in veterinary medicine, providing vets with an advanced tool to manage severe wounds and surgical bleeding.

Landolina founded Cresilon (formerly Suneris) while still a student at New York University, where his passion for science and problem-solving led to the development of the life-saving gel technology. Under his leadership, the company has grown significantly, becoming a leader in veterinary healthcare products. His work has been recognized globally, earning him awards and media attention for his contributions to biotech innovation. Joe Landolina continues to push the boundaries of medical technology, making a significant impact on animal health and emergency care.

Learn more about Cresilon